Effect of concomitant progesterone administration or the effect of removal of estrogen capsule on changes caused by long-term estrogen treatment in pituitary VIP immunoreactivities

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Endocrine

• Publication date

  2010-03-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12020-010-9320-xPMID 20960159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The History of Steroidal Contraceptive Development: The Estrogens

  2015cited by this paper
• Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society

  2008cited by this paper
• Thin endometrium in assisted reproductive technology

  2008cited by this paper
• Oestrogen receptor α and β in female rat pituitary cells: An immunochemical study

  2008cited by this paper
• Alcohol and Estrogen Replacement Therapy in Postmenopausal Women

  2008cited by this paper
• The characteristic change in the distribution of S-100 immunoreactive folliculostellate cells in rat anterior pituitary upon long-term estrogen treatment is prevented by concomitant progesterone treatment

  2008cited by this paper
• Progesterone receptors: form and function in brain.

  2008cited by this paper
• Oestrogen receptor alpha and beta in female rat pituitary cells: an immunochemical study.

  2008cited by this paper
• The integrated action of oestrogen receptor isoforms and sites with progesterone receptor in the gonadotrope modulates LH secretion: evidence from tamoxifen-treated ovariectomized rats.

  2007cited by this paper
• Progestagen therapy for recurrent miscarriage.

  2007cited by this paper
• Implication of Pituitary Vasoactive Intestinal Peptide in Dopaminergic Inhibition of Estrogen-Induced Pituitary Hyperplasia and Vascular Endothelial Growth Factor Expression

  2005cited by this paper
• In vitro immunoblockade of VIP inhibits the proliferation of pituitary prolactin cells

  2005cited by this paper
• Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses.

  2004cited by this paper
• Distribution of estrogen receptor α and β in the mouse central nervous system: In vivo autoradiographic and immunocytochemical analyses

  2004cited by this paper
• Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.

  2003cited by this paper
• Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.

  2003cited by this paper
• The evolving role of estrogen therapy in prostate cancer.

  2002cited by this paper
• Progesterone Receptor A and B Messenger Ribonucleic Acid Levels in the Anterior Pituitary of Rats Are Regulated by Estrogen1

  2000cited by this paper
• Progesterone receptor isoforms expression pattern in the rat brain during the estrous cycle.

  2000cited by this paper
• Ovarian steroids influence the activity of neuroendocrine dopaminergic neurons.

  2000cited by this paper
• Different ultrastructural localization of VIP and prolactin in anterior pituitary cells of rats chronically treated with estrogen

  1996cited by this paper
• Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.

  1996cited by this paper
• Cloning of a novel receptor expressed in rat prostate and ovary.

  1996cited by this paper
• Bioactive peptides in anterior pituitary cells.

  1994cited by this paper
• Transmitter content and afferent connections of estrogen-sensitive progestin receptor-containing neurons in the primate hypothalamus.

  1992cited by this paper
• Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscopic immunohistochemical study.

  1990cited by this paper
• Innervation of different peptide-containing neurons in the hippocampus by GABAergic septal afferents.

  1990cited by this paper
• Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.

  1989cited by this paper
• Neuroendocrine Significance of Vasoactive Intestinal Polypeptide a

  1988cited by this paper
• [Ludwig Haberlandt (l885-l932) and the development of hormonal contraception].

  1988cited by this paper
• Molecular cloning and characterization of rat estrogen receptor cDNA.

  1987cited by this paper
• Hyperprolactinemia reduces vasoactive intestinal peptide in the anterior pituitary glands of rats.

  1987cited by this paper
• Receptor-mediated interrelationships between progesterone and estradiol action on the anterior pituitary-hypothalamic axis of the ovariectomized immature rat.

  1987cited by this paper
• Antisera to vasoactive intestinal polypeptide inhibit basal prolactin release from dispersed anterior pituitary cells.

  1986cited by this paper
• Time course of induction of prolactin-secreting pituitary tumors with diethylstilbestrol in male rats: response of tuberoinfundibular dopaminergic neurons.

  1985cited by this paper
• Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP).

  1984cited by this paper
• Effects of subcutaneous implantation or intrauterine insertion of silastic tube containing steroids on the fertility of rats.

  1970cited by this paper
• The prospects for hormonal sterilization.

  1937cited by this paper
• Printed in U.S.A. Copyright © 1998 by The Endocrine Society Estrogen Receptor- � Messenger Ribonucleic Acid Expression in the Pituitary Gland*

  year unknowncited by this paper

• New insights into progesterone actions on prolactin secretion and prolactinoma development.

  2019cites this paper